Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2007

01-08-2007 | Original Paper

CARD15 Status and Familial Predisposition for Crohn's Disease and Colonic Gene Expression

Authors: Claudio Csillag, Ole Haagen Nielsen, Rehannah Borup, Jørgen Olsen, Jacob Tveiten Bjerrum, Finn Cilius Nielsen

Published in: Digestive Diseases and Sciences | Issue 8/2007

Login to get access

Abstract

Familial disposition and mutations in the Caspase Recruitment Domain 15 (CARD15) have been associated with an increased risk for Crohn's disease (CD). This study investigated whether these risk factors correlate with colonic gene expression profiles generated by DNA-microarray technology. Tissue specimens from descending colon were obtained during colonoscopy from 45 CD patients (18 from areas with inflammation and 27 from noninflamed areas). Gene profiling analysis was performed using the Human Genome U133 Plus 2.0 GeneChip Array. Patients were classified according to their CARD15 status. Hybridization data were analyzed with dChip software. Nine patients with either one or two CARD15 mutations had no differentially expressed genes, compared to 36 patients with wild- type CARD15. There was only one differentially expressed EST between 8 patients who had familial disposition for inflammatory bowel disease (IBD) and 36 who did not, but hierarchical cluster analysis did not show group homogeneity. We conclude that gene expression profiling of mucosal biopsies from the descending colon of patients with CD could not be correlated with CARD15 status or with familial disposition for IBD.
Literature
1.
go back to reference Hanauer SB (2006) Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12(Suppl 1):S3–S9PubMedCrossRef Hanauer SB (2006) Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12(Suppl 1):S3–S9PubMedCrossRef
2.
go back to reference Ott SJ, Musfeldt M, Wenderoth DF, et al. (2004) Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53:685–693PubMedCrossRef Ott SJ, Musfeldt M, Wenderoth DF, et al. (2004) Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53:685–693PubMedCrossRef
3.
go back to reference Swidsinski A, Ladhoff A, Pernthaler A, et al. (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122:44–54PubMedCrossRef Swidsinski A, Ladhoff A, Pernthaler A, et al. (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122:44–54PubMedCrossRef
4.
go back to reference Darfeuille-Michaud A, Boudeau J, Bulois P, et al. (2004) High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127:412–421PubMedCrossRef Darfeuille-Michaud A, Boudeau J, Bulois P, et al. (2004) High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127:412–421PubMedCrossRef
5.
go back to reference Seksik P, Rigottier-Gois L, Gramet G, et al. (2003) Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52:237–242PubMedCrossRef Seksik P, Rigottier-Gois L, Gramet G, et al. (2003) Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52:237–242PubMedCrossRef
6.
go back to reference Sokol H, Seksik P, Rigottier-Gois L, et al. (2006) Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 12:106–111PubMedCrossRef Sokol H, Seksik P, Rigottier-Gois L, et al. (2006) Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 12:106–111PubMedCrossRef
7.
go back to reference Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI (2001) Molecular analysis of commensal host-microbial relationships in the intestine. Science 291:881–884PubMedCrossRef Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI (2001) Molecular analysis of commensal host-microbial relationships in the intestine. Science 291:881–884PubMedCrossRef
8.
go back to reference Nielsen SE, Nielsen OH, Vainer B, Claesson MH (2002) Inflammatory bowel disease—Do microorganisms play a role? Ugeskr Laeger 164:5947–5950PubMed Nielsen SE, Nielsen OH, Vainer B, Claesson MH (2002) Inflammatory bowel disease—Do microorganisms play a role? Ugeskr Laeger 164:5947–5950PubMed
9.
go back to reference Mathew CG, Lewis CM (2004) Genetics of inflammatory bowel disease: progress and prospects. Hum Mol Genet 13(Spec. No. 1):R161–R168PubMedCrossRef Mathew CG, Lewis CM (2004) Genetics of inflammatory bowel disease: progress and prospects. Hum Mol Genet 13(Spec. No. 1):R161–R168PubMedCrossRef
10.
go back to reference Hugot JP, Chamaillard M, Zouali H, et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599–603PubMedCrossRef Hugot JP, Chamaillard M, Zouali H, et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599–603PubMedCrossRef
11.
go back to reference Ogura Y, Bonen DK, Inohara N, et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603–606PubMedCrossRef Ogura Y, Bonen DK, Inohara N, et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603–606PubMedCrossRef
12.
go back to reference Cuthbert AP, Fisher SA, Mirza MM, et al. (2002) The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 122:867–874PubMedCrossRef Cuthbert AP, Fisher SA, Mirza MM, et al. (2002) The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 122:867–874PubMedCrossRef
13.
go back to reference Vermeire S, Wild G, Kocher K, et al. (2002) CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet 71:74–83PubMedCrossRef Vermeire S, Wild G, Kocher K, et al. (2002) CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet 71:74–83PubMedCrossRef
14.
go back to reference Hampe J, Grebe J, Nikolaus S, et al. (2002) Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 359:1661–1665PubMedCrossRef Hampe J, Grebe J, Nikolaus S, et al. (2002) Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 359:1661–1665PubMedCrossRef
15.
go back to reference Alvarez-Lobos M, Arostegui JI, Sans M, et al. (2005) Crohn's disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence. Ann Surg 242:693–700PubMedCrossRef Alvarez-Lobos M, Arostegui JI, Sans M, et al. (2005) Crohn's disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence. Ann Surg 242:693–700PubMedCrossRef
16.
go back to reference Russell RK, Drummond HE, Nimmo EE, et al. (2005) Genotype-phenotype analysis in childhood-onset Crohn's disease: NOD2/CARD15 variants consistently predict phenotypic characteristics of severe disease. Inflamm Bowel Dis 11:955–964PubMedCrossRef Russell RK, Drummond HE, Nimmo EE, et al. (2005) Genotype-phenotype analysis in childhood-onset Crohn's disease: NOD2/CARD15 variants consistently predict phenotypic characteristics of severe disease. Inflamm Bowel Dis 11:955–964PubMedCrossRef
17.
18.
go back to reference Ahmad T, Armuzzi A, Bunce M, et al. (2002) The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 122:854–866PubMedCrossRef Ahmad T, Armuzzi A, Bunce M, et al. (2002) The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 122:854–866PubMedCrossRef
19.
go back to reference Abreu MT, Taylor KD, Lin YC, et al. (2002) Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 123:679–688PubMedCrossRef Abreu MT, Taylor KD, Lin YC, et al. (2002) Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 123:679–688PubMedCrossRef
20.
go back to reference Lesage S, Zouali H, Cezard JP, et al. (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70:845–857PubMedCrossRef Lesage S, Zouali H, Cezard JP, et al. (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70:845–857PubMedCrossRef
21.
go back to reference Barcelo-Batllori S, Andre M, Servis C, et al. (2002) Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases. Proteomics 2:551–560PubMedCrossRef Barcelo-Batllori S, Andre M, Servis C, et al. (2002) Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases. Proteomics 2:551–560PubMedCrossRef
22.
go back to reference Langmann T, Moehle C, Mauerer R, et al. (2004) Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology 127:26–40PubMedCrossRef Langmann T, Moehle C, Mauerer R, et al. (2004) Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology 127:26–40PubMedCrossRef
23.
go back to reference Li J, Moran T, Swanson E, et al. (2004) Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Hum Mol Genet 13:1715–1725PubMedCrossRef Li J, Moran T, Swanson E, et al. (2004) Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Hum Mol Genet 13:1715–1725PubMedCrossRef
24.
go back to reference Dooley TP, Curto EV, Reddy SP, et al. (2004) Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays. Inflamm Bowel Dis 10:1–14PubMedCrossRef Dooley TP, Curto EV, Reddy SP, et al. (2004) Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays. Inflamm Bowel Dis 10:1–14PubMedCrossRef
25.
go back to reference Uthoff SM, Eichenberger MR, Lewis RK, et al. (2001) Identification of candidate genes in ulcerative colitis and Crohn's disease using cDNA array technology. Int J Oncol 19:803–810PubMed Uthoff SM, Eichenberger MR, Lewis RK, et al. (2001) Identification of candidate genes in ulcerative colitis and Crohn's disease using cDNA array technology. Int J Oncol 19:803–810PubMed
26.
go back to reference Lawrance IC, Fiocchi C, Chakravarti S (2001) Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 10:445–456PubMedCrossRef Lawrance IC, Fiocchi C, Chakravarti S (2001) Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 10:445–456PubMedCrossRef
27.
go back to reference Dieckgraefe BK, Stenson WF, Korzenik JR, Swanson PE, Harrington CA (2000) Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genomics 4:1–11PubMed Dieckgraefe BK, Stenson WF, Korzenik JR, Swanson PE, Harrington CA (2000) Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genomics 4:1–11PubMed
28.
go back to reference Zeng H, Carlson AQ, Guo Y, et al. (2003) Flagellin is the major proinflammatory determinant of enteropathogenic Salmonella. J Immunol 171:3668–3674PubMed Zeng H, Carlson AQ, Guo Y, et al. (2003) Flagellin is the major proinflammatory determinant of enteropathogenic Salmonella. J Immunol 171:3668–3674PubMed
29.
go back to reference Fukushima K, Ogawa H, Takahashi K, et al. (2003) Non-pathogenic bacteria modulate colonic epithelial gene expression in germ-free mice. Scand J Gastroenterol 38:626–634PubMedCrossRef Fukushima K, Ogawa H, Takahashi K, et al. (2003) Non-pathogenic bacteria modulate colonic epithelial gene expression in germ-free mice. Scand J Gastroenterol 38:626–634PubMedCrossRef
30.
go back to reference Ogawa H, Fukushima K, Naito H, et al. (2003) Increased expression of HIP/PAP and regenerating gene III in human inflammatory bowel disease and a murine bacterial reconstitution model. Inflamm Bowel Dis 9:162–170PubMedCrossRef Ogawa H, Fukushima K, Naito H, et al. (2003) Increased expression of HIP/PAP and regenerating gene III in human inflammatory bowel disease and a murine bacterial reconstitution model. Inflamm Bowel Dis 9:162–170PubMedCrossRef
31.
go back to reference Csillag C, Nielsen OH, Borup R, Nielsen FC (2005) Microarrays and Crohn's disease: collecting reliable information. Scand J Gastroenterol 40:369–377PubMed Csillag C, Nielsen OH, Borup R, Nielsen FC (2005) Microarrays and Crohn's disease: collecting reliable information. Scand J Gastroenterol 40:369–377PubMed
32.
go back to reference Glebov OK, Rodriguez LM, Nakahara K, et al. (2003) Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev 12:755–762PubMed Glebov OK, Rodriguez LM, Nakahara K, et al. (2003) Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev 12:755–762PubMed
33.
go back to reference Distler P, Holt PR (1997) Are right- and left-sided colon neoplasms distinct tumors? Dig Dis 15:302–311PubMedCrossRef Distler P, Holt PR (1997) Are right- and left-sided colon neoplasms distinct tumors? Dig Dis 15:302–311PubMedCrossRef
34.
go back to reference Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V (1992) Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962–87: a sixfold increase in incidence. Scand J Gastroenterol 27:609–614PubMed Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V (1992) Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962–87: a sixfold increase in incidence. Scand J Gastroenterol 27:609–614PubMed
36.
go back to reference Gasche C, Scholmerich J, Brynskov J, et al. (2000) A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6:8–15PubMedCrossRef Gasche C, Scholmerich J, Brynskov J, et al. (2000) A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6:8–15PubMedCrossRef
37.
go back to reference Wei C, Li J, Bumgarner RE (2004) Sample size for detecting differentially expressed genes in microarray experiments. BMC Genomics 5:87PubMedCrossRef Wei C, Li J, Bumgarner RE (2004) Sample size for detecting differentially expressed genes in microarray experiments. BMC Genomics 5:87PubMedCrossRef
38.
go back to reference Day D, Jass J, Price A, et al. (2003) Morson and Dawson's gastrointestinal pathology. 4th ed. Blackwell Science, Oxford, UK, pp 505–507 Day D, Jass J, Price A, et al. (2003) Morson and Dawson's gastrointestinal pathology. 4th ed. Blackwell Science, Oxford, UK, pp 505–507
39.
go back to reference Chomczynski P (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15:532–537PubMed Chomczynski P (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15:532–537PubMed
40.
go back to reference Li C, Wong WH (2001) Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98:31–36PubMedCrossRef Li C, Wong WH (2001) Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98:31–36PubMedCrossRef
41.
go back to reference WFDC1. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id= 605322 WFDC1. http://​www.​ncbi.​nlm.​nih.​gov/​entrez/​dispomim.​cgi?​id=​ 605322
42.
go back to reference IL1R1. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id= 147810 IL1R1. http://​www.​ncbi.​nlm.​nih.​gov/​entrez/​dispomim.​cgi?​id=​ 147810
43.
go back to reference Bullinger L, Valk PJ (2005) Gene expression profiling in acute myeloid leukemia. J Clin Oncol 23:6296–6305PubMedCrossRef Bullinger L, Valk PJ (2005) Gene expression profiling in acute myeloid leukemia. J Clin Oncol 23:6296–6305PubMedCrossRef
44.
go back to reference Catalano A, Iland H (2005) Molecular biology of lymphoma in the microarray era. Pathology 37:508–522PubMedCrossRef Catalano A, Iland H (2005) Molecular biology of lymphoma in the microarray era. Pathology 37:508–522PubMedCrossRef
45.
go back to reference Rosenwald A, Staudt LM (2002) Clinical translation of gene expression profiling in lymphomas and leukemias. Semin Oncol 29:258–263PubMedCrossRef Rosenwald A, Staudt LM (2002) Clinical translation of gene expression profiling in lymphomas and leukemias. Semin Oncol 29:258–263PubMedCrossRef
46.
go back to reference Morgensztern D, Lossos IS (2005) Molecular prognostic factors in diffuse large B-cell lymphoma. Curr Treat Options Oncol 6:269–277PubMed Morgensztern D, Lossos IS (2005) Molecular prognostic factors in diffuse large B-cell lymphoma. Curr Treat Options Oncol 6:269–277PubMed
47.
go back to reference Valk PJM, Verhaak RGW, Beijen MA, et al. (2004) Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 350:1617–1628PubMedCrossRef Valk PJM, Verhaak RGW, Beijen MA, et al. (2004) Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 350:1617–1628PubMedCrossRef
48.
go back to reference Bullinger L, Dohner K, Bair E, et al. (2004) Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 350:1605–1616PubMedCrossRef Bullinger L, Dohner K, Bair E, et al. (2004) Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 350:1605–1616PubMedCrossRef
49.
go back to reference van’t Veer LJ, Dai H, van de Vijver MJ, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530–536PubMedCrossRef van’t Veer LJ, Dai H, van de Vijver MJ, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530–536PubMedCrossRef
50.
go back to reference van de Vijver MJ, He YD, van't Veer LJ, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999–2009PubMedCrossRef van de Vijver MJ, He YD, van't Veer LJ, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999–2009PubMedCrossRef
51.
go back to reference Bleharski JR, Li H, Meinken C, et al. (2003) Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science 301:1527–1530PubMedCrossRef Bleharski JR, Li H, Meinken C, et al. (2003) Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science 301:1527–1530PubMedCrossRef
52.
go back to reference Mariadason JM, Arango D, Augenlicht LH (2004) Customizing chemotherapy for colon cancer: the potential of gene expression profiling. Drug Resist Updat 7:209–218PubMedCrossRef Mariadason JM, Arango D, Augenlicht LH (2004) Customizing chemotherapy for colon cancer: the potential of gene expression profiling. Drug Resist Updat 7:209–218PubMedCrossRef
53.
go back to reference Pickard KM, Bremner AR, Gordon JN, MacDonald TT (2004) Microbial-gut interactions in health and disease. Immune responses. Best Pract Res Clin Gastroenterol 18:271–285PubMedCrossRef Pickard KM, Bremner AR, Gordon JN, MacDonald TT (2004) Microbial-gut interactions in health and disease. Immune responses. Best Pract Res Clin Gastroenterol 18:271–285PubMedCrossRef
Metadata
Title
CARD15 Status and Familial Predisposition for Crohn's Disease and Colonic Gene Expression
Authors
Claudio Csillag
Ole Haagen Nielsen
Rehannah Borup
Jørgen Olsen
Jacob Tveiten Bjerrum
Finn Cilius Nielsen
Publication date
01-08-2007
Published in
Digestive Diseases and Sciences / Issue 8/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9737-5

Other articles of this Issue 8/2007

Digestive Diseases and Sciences 8/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.